Nephros (NEPH) Research & Development (2010 - 2026)
Nephros' (NEPH) quarterly Research & Development came in at $346000.0 in Q1 2026, up 17.29% year-on-year from $295000.0 in Q1 2025, and down 12.41% quarter-over-quarter from $395000.0 in Q4 2025.
Nephros (NEPH) Research & Development (2010 - 2026) Analysis & Trends
Nephros' Research & Development history runs 17 years deep, the most recent figure standing at $346000.0 for Q1 2026.
- On a quarterly basis, Research & Development rose 17.29% year-over-year to $346000.0 in Q1 2026; TTM through Mar 2026 was $1.4 million, a 40.55% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 47.79% from the prior year.
- Research & Development fell to $346000.0 in Q1 2026 per NEPH's latest filing, from $395000.0 in the prior quarter.
- Across five years, Research & Development topped out at $395000.0 in Q4 2025 and bottomed at $188000.0 in Q3 2024.
- The 5-year median for Research & Development is $254000.0 (2024), against an average of $277647.1.
- Across the five-year window, Research & Development slumped 43.94% in 2022 and jumped 79.79% in 2025, its largest moves.
- Year by year, Research & Development stood at $359000.0 in 2022, then plunged by 42.06% to $208000.0 in 2023, then rose by 21.15% to $252000.0 in 2024, then surged by 56.75% to $395000.0 in 2025, then fell by 12.41% to $346000.0 in 2026.
- Per Business Quant, the three latest NEPH Research & Development figures stand at $346000.0 (Q1 2026), $395000.0 (Q4 2025), and $338000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -245.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 249.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 94.27 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 189.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 98.66 Mn |
| 10 | Nephros | 40.88 Mn | 36.86 Mn | 2.99 Mn | 346,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 346,000.00 |
| Dec 31, 2025 | 395,000.00 |
| Sep 30, 2025 | 338,000.00 |
| Jun 30, 2025 | 311,000.00 |
| Mar 31, 2025 | 295,000.00 |
| Dec 31, 2024 | 252,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 254,000.00 |
| Mar 31, 2024 | 212,000.00 |
| Dec 31, 2023 | 208,000.00 |
| Sep 30, 2023 | 205,000.00 |
| Jun 30, 2023 | 221,000.00 |
| Mar 31, 2023 | 239,000.00 |
| Dec 31, 2022 | 359,000.00 |
| Sep 30, 2022 | 252,000.00 |
| Jun 30, 2022 | 273,000.00 |
| Mar 31, 2022 | 372,000.00 |
| Dec 31, 2021 | 328,000.00 |
| Sep 30, 2021 | 395,000.00 |
| Jun 30, 2021 | 487,000.00 |